Mannan-binding lectin in malignancy

Molecular Immunology

Volumn 55, Issue 1, 2013, Pages 16-21

  Swierzko, Anna S ^a   Kilpatrick, David C ^b   Cedzynski, Maciej ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Cancer; Innate immunity; Mannan binding lectin; MBL2

Indexed keywords

ANAPHYLATOXIN; CELL RECEPTOR; COMPLEMENT; MANNAN BINDING LECTIN; POLYMER;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CELL MEDIATED CYTOTOXICITY; CHEMOTAXIS; CHROMOSOME 10; COLON CANCER; COLORECTAL CANCER; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DNA POLYMORPHISM; FEBRILE NEUTROPENIA; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GYNECOLOGIC CANCER; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION; INFECTION RISK; INFLAMMATION; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; NEOPLASM; OPSONIZATION; OVARY CANCER; PANCREAS CANCER; PATTERN RECOGNITION; PHAGOCYTOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEOMICS; RECEPTOR BINDING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SUBSTITUTION THERAPY; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ANIMALS; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; HUMANS; MANNOSE-BINDING LECTIN; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN MULTIMERIZATION;

EID: 84875620486     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.09.005     Document Type: Review

References (63)

1. Baccarelli A., Hou L., Chen J., Lissowska J., El-Omra E.M., Grillo P., Giacomini S.M., Yaeger M., Bernig T., Zatonski W., Fraumeni J.F., Chanock S.J., Chow W.H. Mannose-binding lectin-2 genetic variation and stomach cancer risk. International Journal of Cancer 2006, 119:1970-1975.
2. Bergmann O.J., Christiansen M.J., Laursen I., Bang P., Hansen N.E., Ellegaard J., Koch C., Andersen V. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. European Journal of Haematology 2003, 70:91-97.
3. Bernig T., Boersma B.J., Howe T.M., Welch R., Yadavalli S., Staats B., Mechanic L.E., Chanock S.J., Ambs S. The mannose-binding lectin (MBL2) haplotype and breast cancer: and association study in African American and Caucasian women. Carcinogenesis 2007, 28:828-836.
4. Bernig T., Breunis W., Brouwer N., Hutchinson A., Welch R., Roos D., Kujipers T., Chanock S. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannose-binding lectin. Human Genetics 2005, 118:404-415.
5. Boldt A.B.W., Messias-Reason I.J., Meyer D., Schrago C.G., Lang F., Lell B., Dietz K., Kremsner P.G., Petzl-Erler M.L., Kun J.F.J. Phylogenic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genetics 2010, 11:38.
6. Eurich D., Boas-Knoop S., Morawietz L., Neuhaus R., Somasundaram R., Ruehl M., Neumann U.P., Neuhaus P., Bahra M., Seehofer D. Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma. Liver International 2011, 31:1006-1012.
7. Ezekowitz R.A., Kuhlman M., Groopman J.E., Byrn R.A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. Journal of Experimental Medicine 1989, 169:185-196.
8. Fisch U.P., Zehnder A., Hirt A., Niggli F.K., Simon A., Ozsahin H., Schlapbach L.J., Ammann R.A. Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer. Swiss Medical Weekly 2011, 141:w13191.
9. Frakking F.N., Brouwer N., Dolman K.M., van Woensel J.B., Caron H.N., Kuijpers T.W., van de Wetering M.D. Mannose-binding lectin (MBL) as prognostic factor in pediatric oncology patients. Clinical and Experimental Immunology 2011, 165:51-59.
10. Frakking F.N., Brouwer N., van de Wetering M.D., Budde I.K., Strengers P.F., Huitema A.D., Laursen I., Houen G., Dolman K.M., Kuijpers T.W. Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. European Journal of Cancer 2009, 45:505-512.
11. Frakking F.N., van de Wetering M.D., Brouwer N., Dolman K.M., Geissler J., Lemkes B., Caron H.N., Kujipers T.W. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. European Journal of Cancer 2006, 42:909-916.
12. Frakking F.N.J., Israels J., Kremer I.C.M., Kujipers T.W., Caron H.N., van de Wetering M.D. Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy. Pediatric Blood and Cancer 2011, 57:89-96.
13. Fujita T., Taira S., Kodama N., Matsushita M., Fujita T. Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway. Japanese Journal of Cancer Research 1995, 86:187-192.
14. Ghazi M., Isadyar M., Gachkar L., Mahmoudi S., Goudarzi H., Eslami G., Pourakbari B., Fallah F. Serum levels of mannose-binding lectin and the risk of infection in pediatric oncology patients with chemotherapy. Journal of Pediatric Hematology/Oncology 2012, 34:128-130.
15. Guimaraes V., Brandai L., Baldez da Silva M.F., Milanese M., Segat L., Castelletti H., Bruneska D.M., de Lima Filho J.L., de Freitas A.C., Arraes L.C., Rocha C., Crovella S. Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women. Human Immunology 2008, 69:273-278.
16. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1-231-1-233.
17. Hansen S., Holmskov U. Structural aspects of collectins and receptors for collectins. Immunobiology 1998, 199:165-189.
18. Heitzeneder S., Seidel M., Forster-Waldl E., Heitger A. Mannan-binding lectin deficiency - good news, bad news, doesn't matter?. Clinical Immunology 2012, 143:22-38.
19. Hirano M., Ma B.Y., Kawasaki N., Okimura K., Baba M., Nakagawa T., Miwa K., Kawasaki N., Oka S., Kawasaki T. Mannan-binding protein blocks the activation of metalloproteases meprin α and β. Journal of Immunology 2005, 175:3177-3185.
20. Hodge S., Matthews G., Dean M.M., Ahern J., Djukic M., Hodge G., Jersmann H., Holmes M., Reynolds P.M. Therapeutic role for mannose-binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. American Journal of Respiratory Cell and Molecular Biology 2010, 42:235-242.
21. Horiuchi T., Gondo H., Miyagawa H., Otsuka J., Inaba S., Nagafuji K., Takase K., Tsukamoto H., Koyama T., Mitoma H., Tamimoto Y., Miyagi Y., Tahira T., Hayashi K., Hashimura C., Okamura S., Harada M. Association of MBL gene polymorphism with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes and Immunity 2005, 2:162-166.
22. Kawasaki N., Lin Ch W., Inoue R., Khoo K.H., Kawasaki N., Ma B.Y., Oka S., Ishiguro M., Sawada T., Ishida H., Hashimoto T., Kawasaki T. Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. Glycobiology 2009, 19:437-450.
23. Kilpatrick D.C., McLintock L.A., Allan E.K., Copland M., Fujita T., Jordanides N.E., Koch C., Matsushita M., Shiraki H., Stewart K., Tsjujimura M., Turner M.L., Franklin I.M. No strong relationship between mannan binding lectin or plasma ficolin and chemotherapy-related infections. Clinical and Experimental Immunology 2003, 134:279-284.
24. Klostergaard A., Steffensen R., Moller J.K., Peterslund N., Juhl-Christensen C., Molle I. Sepsis in acute myeloid leukaemia patients receiving high-dose chemotherapy: no impact of chitotriosidase and mannose-binding lectin polymorphisms. European Journal of Haematology 2010, 85:58-64.
25. Laursen B., Schmiegielow K., Andreassen B., Madsen H.O., Garred P. Infections during induction therapy of childhood lymphoblastic leukemia - no association to mannose-binding lectin deficiency. European Journal of Haematology 2006, 76:481-487.
26. Lehrnbecher T., Vanzon D., de Haas M., Chanock S.J., Kuhl J. Assessement of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clinical Infectious Diseases 1999, 29:414-419.
27. Ma Y., Uemura K., Oka S., Kozutsumi Y., Kawasaki N. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding protein-dependent cell-mediated cytotoxity. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:371-375.
28. Maaloe N., Bonde C., Laursen I., Christiansen M., Holmich L.R. Mannan-binding lectin and healing of radiation-induced chronic ulcer - a case report on mannan-binding lectin replacement therapy. Journal of Plastic, Reconstructive and Aesthetic Surgery 2011, 64:e146-e148.
29. Madsen H.O., Garred P., Thiel S., Kurzhals J.A., Lamm L.U., Ryder L.P., Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. Journal of Immunology 1995, 155:3013-3020.
30. Maffei G., Brouwer N., Dolman K.M., van der Velden U., Roos D., Loos B.D. Plasma levels of mannan-binding lectin in relation to peridontitis and smoking. Journal of Periodontology 2005, 76:1881-1889.
31. Markiewski M.M., Lambris J.D. Is complement good or bad for cancer patients? A new perspective on an old dilemma. Trends in Immunology 2009, 30:286-292.
32. Martinez-Lopez J., Rivero A., Rapado I., Montalban C., Paz-Carreira J., Canales M., Martinez R., Sanchez-Godoy P., Fernandez de Sevilla A., Penalver F.J., Gonzalez M., Prieto E., Salar A., Burgaleta C., Queizan J.A., Penarrubia M.J., Monteagudo M.D., Cabrera C., De la Serna J., Tomas J.F. Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine and cyclophosphamide. Leukemia and Lymphoma 2009, 50:1283-1289.
33. Molle I., Peterslund N.A., Thiel S., Steffensen R. MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplantation 2006, 38:555-560.
34. Molle I., Steffensen R., Thiel S., Peterslund N.A. Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes. European Journal of Haematology 2006, 77:19-26.
35. Muto S., Sakuma K., Taniguchi A., Matsumoto K. Human mannose-binding lectin preferentially binds to human colon adenocarcinoma cell lines expressing high amout of Lewis A and Lewis B antigens. Biological and Pharmaceutical Bulletin 1999, 22:347-352.
36. Muto S., Takada T., Matsumoto K. Biological activites of human mannose-binding lectin bound to two different ligand structures, Lewis A and Lewis B antigens and high-mannose type oligosaccharides. Biochimica et Biophysica Acta 2001, 1527:39-46.
37. Nauta A.J., Raashou-Jensen N., Roos A., Daha M.R., Madsen H.O., Borrias-Essers M.C., Ryder L.P., Koch C., Garred P. Mannose-binding lectin engagement with late apoptotic and necrotic cells. European Journal of Immunology 2003, 33:2853-2863.
38. Neth O., Hann I., Turner M.W., Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001, 358:614-618.
39. Nevadunsky N.S., Korneeva I., Caputo T., Witkin S.S. Mannose-binding lectin codon 54 genetic polymorphism and vaginal protein levels in women with gynecologic malignancies. European Journal of Obstetrics and Gynecology and Reproductive Biology 2012, 163:216-218.
40. Olivo-Marston S., Yang P., Mechani L.E., Bowman E.D., Pine S.H., Loffredo C.A., Alberg A.J., Caporaso N., Shields P.G., Chanock S., Wu Y., Jiang R., Cunnigham J., Jen J., Harris C.C. Childhood exposure to second smoke and functional mannose binding lectin polymorphism are associated with increased lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2009, 18:3375-3383.
41. Peterslund N.A., Koch C., Jensenius J.C., Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. The Lancet 2001, 358:637-638.
42. Pine S.R., Mechanic L.E., Ambs S., Bowman E.D., Chanock S.J., Loffredo Ch Shields P.G., Haris X.C. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. Journal of the National Cancer Institute 2007, 99:1401-1409.
43. Rong Y., Jin D., Hou C., Hu J., Wu W., Ni X., Wang D., Lou W. Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterology 2010, 10:68.
44. Rubnitz J.E., Howard S.C., Willis J., Pui C.H., Pounds S., Hayden R.T. Baseline mannose binding lectin levels may not predict infection among children with leukemia. Pediatric Blood and Cancer 2008, 50:866-868.
45. Schlapbach L.J., Aebi C., Otth M., Ridolfi Luethy A., Leibundgut K., Hirt A., Ammann R.A. Serum levels of mannose-binding lectin and the risk of fever in neutropenic pediatric cancer patients. Pediatric Blood and Cancer 2007, 49:11-16.
46. Schmiegelow K., Garred P., Lausen B., Andreassen B., Petersen B.L., Madsen H.O. Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. Blood 2002, 100:3757-3760.
47. Scudiero O., Nardone G., Omodei D., Tatangelo F., Vitale D.F., Dalvatore F., Castaldo G. A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clinical Chemistry 2006, 52:1625-1626.
48. Segat L., Crovella S., Comar M., Milanese M., Zanotta N., Fabris A., Trevisio C., Rossi T., De Seta F., Campello C. MBL2 gene polymorphisms are connected with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer. Human Immunology 2009, 70:436-439.
49. Segat L., Fabris A., Padovan L., Milanese M., Piruli D., Lupo F., Salizzoni M., Amoroso A., Crovella S. MBL2 and MASP2 polymorphisms in patients with hepatocellular carcinoma. Journal of Viral Hepatitis 2008, 15:387-391.
50. Svendsen M.N., Ytting H., Brunner N., Nielsen H.J., Christensen I.J. Preoperative concentrations of suPAR and MBL proteins are associated with the development of pneumonia after selective surgery for colorectal cancer. Surgical Infections 2006, 7:463-471.
51. Swierzko A.S., Florczak K., Cedzynski M., Szemraj J., Wydra D., Bak-Romaniszyn L., Emerich J., Sulowska Z. Mannan-binding lectin (MBL) in women with tumours of the reproductive system. Cancer Immunology, Immunotherapy 2007, 56:959-971.
52. Terada M., Khoo K.H., Inoue R., Chen C.I., Yamada K., Sakaguchi H., Kadowaki N., Ma B.Y., Oka S., Kawasaki T., Kawasaki N. Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N-glycan. Journal of Biological Chemistry 2005, 280:10897-10913.
53. Thiel S., Gadjeva M. Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Advances in Experimental Medicine and Biology 2009, 653:58-73.
54. Tomaiuolo R., Ruocco A., Salapete C., Carrus C., Baggio G., Franceschi C., Zinellu A., Vaupel J., Bellia C., Lo Sasso B., Ciaccio M., Castaldo G., Deiana L. Activity of mannose-binding (MBL) in centenarians. Aging Cell 2012, 11:394-400.
55. Van der Bol J.M., de Jong F.A., van Schaik R.H., Sparreboom A., van Fessem M.A., van de Geijn F.E., van Daele P.L., Verweij J., Sleijfer S., Mathijssen R.H. Effects of mannose-binding lectin polymorphism on irinotecan-induced febrile neutropenia. The Oncologist 2010, 15:1063-1072.
56. Vekemans M., Robinson J., Georgala A., Heymans C., Muanza F., Peasmans M., Klastersky J., Barette M., Meuleman N., Huet F., Calandra T., Constantini S., Ferrant A., Mathissen F., Axelsen M., Marchetti O., Aoun M. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who undergoing chemotherapy. Clinical Infectious Diseases 2007, 44:1593-1601.
57. Wang F-Y., Tahara T., Arisawa T., Shibata T., Yamashita H., Nakamura M., Yoshioka D., Okubo M., Maruyama N., Kamano T., Kamiya C., Nakamura M., Fujita H., Nagasaka M., Iwata M., Takahama K., Watanabe M., Nakano H., Hirata I. Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population. Digestive Diseases and Sciences 2008, 53:2904-2908.
58. Wang M., Chen Y., Zhang Y., Zhang L., Lu X., Chen Z. Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cellular and Molecular Immunology 2011, 8:265-275.
59. Wong M., Ohrmalm L., Broliden K., Aust C., Hibberd M., Tolfvenstam T. Mannose-binding lectin-2 polymorphisms do not influence frequency or type of infection in adults with chemotherapy induced neutropenia. PLoS ONE 2012, 7:e30819.
60. Ytting H., Christensen I.J., Jensenius J.C., Thiel S., Nielsen H.J. Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer. Cancer Immunology, Immunotherapy 2005, 54:265-272.
61. Ytting H., Christensen I.J., Steffensen R., Alsner J., Thiel S., Jensenius J.C., Hansen U., Nielsen H.J. Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Scandinavian Journal of Immunology 2011, 73:122-127.
62. Ytting H., Jensenius J.C., Christensen I.J., Thiel S., Nielsen H.J. Increased activity of the mannan-binding lectin complement pathway in patients with colorectal cancer. Scandinavian Journal of Gastroenterology 2004, 39:670-674.
63. Zanetti K.A., Haznader M., Welsh J.A., Robles A.I., Ryan B.M., McClary A.C., Bowman E.D., Goodman J.E., Bernig T., Chanock S.J., Harris C.C. 3'UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Research 2012, 72:1467-1677.